Literature DB >> 21145846

Liver transplantation using fatty livers: always feasible?

Lucas McCormack1, Philipp Dutkowski, Ashraf Mohammad El-Badry, Pierre-Alain Clavien.   

Abstract

Steatotic liver grafts represent the most common type of "extended criteria" organs that have been introduced during the last two decades due to the disparity between liver transplant candidates and the number available organs. A precise definition and reliable and reproducible method for steatosis quantification is currently lacking and the potential influence of the chemical composition of hepatic lipids has not been addressed. In our view, these shortcomings appear to contribute significantly to the inconsistent results of studies reporting on graft steatosis and the outcome of liver transplantation. In this review, various definitions, prevalence and methods of quantification of liver steatosis will be covered. Ischemia/reperfusion injury of the steatotic liver and its consequences on post-transplant outcome will be discussed. Selection criteria for organ allocation and a number of emerging protective strategies are suggested.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21145846     DOI: 10.1016/j.jhep.2010.11.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  85 in total

1.  Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.

Authors:  Hussam Alamri; Nathan Heath Patterson; Ethan Yang; Pablo Zoroquiain; Anthoula Lazaris; Pierre Chaurand; Peter Metrakos
Journal:  Anal Bioanal Chem       Date:  2018-12-05       Impact factor: 4.142

Review 2.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Resolution of donor non-alcoholic fatty liver disease following liver transplantation.

Authors:  Andrew D Posner; Samuel T Sultan; Norann A Zaghloul; William S Twaddell; David A Bruno; Steven I Hanish; William R Hutson; Laci Hebert; Rolf N Barth; John C LaMattina
Journal:  Clin Transplant       Date:  2017-07-13       Impact factor: 2.863

4.  An ultrasonic caliper device for measuring acoustic nonlinearity.

Authors:  Christopher Hunter; Oleg A Sapozhnikov; Adam D Maxwell; Vera A Khokhlova; Yak-Nam Wang; Brian MacConaghy; Wayne Kreider
Journal:  Phys Procedia       Date:  2016

Review 5.  Transplant for the very sick: No limitations in donor quality?

Authors:  Jennifer C Lai
Journal:  Liver Transpl       Date:  2017-10       Impact factor: 5.799

6.  Extended criteria donors in liver transplantation-from marginality to mainstream.

Authors:  Amit Nair; Koji Hashimoto
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

7.  Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition.

Authors:  Xiangdong Wang; Christopher J Walkey; Ana C Maretti-Mira; Lei Wang; Deborah L Johnson; Laurie D DeLeve
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.425

Review 8.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

9.  Lipid droplets disrupt mechanosensing in human hepatocytes.

Authors:  LiKang Chin; Neil D Theise; Abigail E Loneker; Paul A Janmey; Rebecca G Wells
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-05-28       Impact factor: 4.052

10.  Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.